000819511 001__ 819511
000819511 005__ 20220930130107.0
000819511 0247_ $$2doi$$a10.1002/chem.201601701
000819511 0247_ $$2ISSN$$a0947-6539
000819511 0247_ $$2ISSN$$a1521-3765
000819511 0247_ $$2WOS$$aWOS:000380270500009
000819511 0247_ $$2altmetric$$aaltmetric:7271514
000819511 0247_ $$2pmid$$apmid:27135646
000819511 037__ $$aFZJ-2016-05154
000819511 041__ $$aEnglish
000819511 082__ $$a540
000819511 1001_ $$0P:(DE-Juel1)151182$$aBarz, Bogdan$$b0$$ufzj
000819511 245__ $$aUnderstanding Amyloid-β Oligomerization at the Molecular Level: The Role of the Fibril Surface
000819511 260__ $$aWeinheim$$bWiley-VCH$$c2016
000819511 3367_ $$2DRIVER$$aarticle
000819511 3367_ $$2DataCite$$aOutput Types/Journal article
000819511 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1476886436_7928
000819511 3367_ $$2BibTeX$$aARTICLE
000819511 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000819511 3367_ $$00$$2EndNote$$aJournal Article
000819511 520__ $$aThe aggregation of the amyloid β-peptide into fibrils is a complex process that involves mechanisms such as primary and secondary nucleation, fibril elongation and fibril fragmentation. Some of these processes generate neurotoxic Aβ oligomers, which are involved in the development of Alzheimer's disease. Recent experimental studies have emphasized the role of the fibril as a catalytic surface for the production of highly toxic oligomers during secondary nucleation. By using molecular dynamics simulations, we show that it is the hydrophobic fibril region that causes the structural changes required for catalyzing the formation of β-sheet-rich Aβ1-42 oligomers on the fibril surface. These results reveal, for the first time, the molecular basis of the secondary nucleation pathway.
000819511 536__ $$0G:(DE-HGF)POF3-553$$a553 - Physical Basis of Diseases (POF3-553)$$cPOF3-553$$fPOF III$$x0
000819511 588__ $$aDataset connected to CrossRef
000819511 7001_ $$0P:(DE-Juel1)132024$$aStrodel, Birgit$$b1$$eCorresponding author$$ufzj
000819511 773__ $$0PERI:(DE-600)1478547-x$$a10.1002/chem.201601701$$gVol. 22, no. 26, p. 8768 - 8772$$n26$$p8768 - 8772$$tChemistry - a European journal$$v22$$x0947-6539$$y2016
000819511 8564_ $$uhttps://juser.fz-juelich.de/record/819511/files/Understanding%20Amyloid-%CE%B2%20Oligomerization%20at%20the%20Molecular%20Level%3A%20The%20Role%20of%20the%20Fibril%20Surface_2016.pdf$$yRestricted
000819511 8564_ $$uhttps://juser.fz-juelich.de/record/819511/files/Understanding%20Amyloid-%CE%B2%20Oligomerization%20at%20the%20Molecular%20Level%3A%20The%20Role%20of%20the%20Fibril%20Surface_2016.pdf?subformat=pdfa$$xpdfa$$yRestricted
000819511 8767_ $$92016-07-21$$d2016-08-24$$eColour charges$$jZahlung erfolgt
000819511 909CO $$ooai:juser.fz-juelich.de:819511$$pOpenAPC$$pVDB$$popenCost
000819511 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)151182$$aForschungszentrum Jülich$$b0$$kFZJ
000819511 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132024$$aForschungszentrum Jülich$$b1$$kFZJ
000819511 9131_ $$0G:(DE-HGF)POF3-553$$1G:(DE-HGF)POF3-550$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lBioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences$$vPhysical Basis of Diseases$$x0
000819511 9141_ $$y2016
000819511 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000819511 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCHEM-EUR J : 2015
000819511 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCHEM-EUR J : 2015
000819511 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000819511 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000819511 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000819511 915__ $$0StatID:(DE-HGF)0550$$2StatID$$aNo Authors Fulltext
000819511 915__ $$0StatID:(DE-HGF)1150$$2StatID$$aDBCoverage$$bCurrent Contents - Physical, Chemical and Earth Sciences
000819511 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000819511 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000819511 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000819511 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000819511 920__ $$lyes
000819511 9201_ $$0I:(DE-Juel1)ICS-6-20110106$$kICS-6$$lStrukturbiochemie $$x0
000819511 980__ $$ajournal
000819511 980__ $$aVDB
000819511 980__ $$aUNRESTRICTED
000819511 980__ $$aI:(DE-Juel1)ICS-6-20110106
000819511 980__ $$aAPC
000819511 981__ $$aI:(DE-Juel1)IBI-7-20200312